RecruitingNCT07112924
CCM OPEN HF Registry
CCM Technologies OPEN HF Registry: Observational Patient EvaluatioN of CCM® Therapy for Heart Failure
Sponsor
Impulse Dynamics
Enrollment
5,500 participants
Start Date
Nov 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patients who have /will be implanted with Impulse Dynamics CCM technologies (e.g. CCM or CCM-D when available) as determined by investigators
- Willing and able to provide informed consent, including for use of data for research purposes (e.g. publication, sub-studies/sub-analyses)
Exclusion Criteria2
- Noncompliant patients (e.g. for follow-up visits, medication, etc.) as determined by investigators.
- Subjects with a mechanical tricuspid valve
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07112924
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location